Src/ERK but not phospholipase D is involved in keratinocyte growth factor-stimulated secretion of matrix metalloprotease-9 and urokinase-type plasminogen activator in SNU-16 human stomach cancer cell

J Cancer Res Clin Oncol. 2002 Nov;128(11):596-602. doi: 10.1007/s00432-002-0388-4. Epub 2002 Oct 23.

Abstract

Purpose: We investigated the signaling pathway for keratinocyte growth factor (KGF)-induced invasion using human stomach cancer cell line, SNU-16.

Methods: Alterations in the activities of Src, extracellular signal-regulated kinase (ERK), and phospholipase D (PLD) were measured using [gamma-(32)P] ATP for autophosphorylation of Src, phospho-specific ERK antibody, and [9,10-(3)H] myristic acid, respectively, while herbimycin A, PD98059 and butan-1-ol were used to inhibit their activities. Matrix metalloproteases (MMPs) and urokinase-type plasminogen activator (uPA) were quantified with zymography and Matrigel-coated Transwell was employed to estimate the invasiveness of SNU-16 cells.

Results: Src, ERK, and PLD were activated in response to KGF treatment, and inhibition of these enzymes - by their specific inhibitors - decreased KGF-induced invasion in a dose-dependent manner. However, only inhibition of Src and ERK could block KGF-stimulated secretion of uPA and MMP-9.

Conclusion: Src, ERK, and PLD are suggested as mediators of KGF-induced invasion in SNU-16. uPA and MMP-9 are considered as downstream targets of Src and ERK whereas PLD is thought to utilize different pathways.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Calcium-Calmodulin-Dependent Protein Kinases / antagonists & inhibitors
  • Collagen / chemistry
  • Drug Combinations
  • Enzyme Inhibitors / pharmacology
  • Fibroblast Growth Factor 7
  • Fibroblast Growth Factors / pharmacology*
  • Flavonoids / pharmacology
  • Humans
  • Laminin / chemistry
  • Matrix Metalloproteinase 9 / metabolism*
  • Mitogen-Activated Protein Kinases / metabolism*
  • Neoplasm Invasiveness
  • Phospholipase D / metabolism*
  • Phosphorylation
  • Proteoglycans / chemistry
  • Proto-Oncogene Proteins pp60(c-src) / metabolism*
  • Receptor, Fibroblast Growth Factor, Type 2
  • Receptors, Fibroblast Growth Factor / metabolism
  • Signal Transduction
  • Stomach Neoplasms / drug therapy
  • Stomach Neoplasms / metabolism*
  • Stomach Neoplasms / pathology
  • Tumor Cells, Cultured / drug effects
  • Urokinase-Type Plasminogen Activator / metabolism*

Substances

  • Drug Combinations
  • Enzyme Inhibitors
  • FGF7 protein, human
  • Flavonoids
  • Laminin
  • Proteoglycans
  • Receptors, Fibroblast Growth Factor
  • matrigel
  • Fibroblast Growth Factor 7
  • Fibroblast Growth Factors
  • Collagen
  • Receptor, Fibroblast Growth Factor, Type 2
  • keratinocyte growth factor receptor
  • Proto-Oncogene Proteins pp60(c-src)
  • Calcium-Calmodulin-Dependent Protein Kinases
  • Mitogen-Activated Protein Kinases
  • Phospholipase D
  • Urokinase-Type Plasminogen Activator
  • Matrix Metalloproteinase 9
  • 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one